companydata.dkcompanydata.dk

Serenova A/S: Financial statements 2016

CVR: 30532228

Source: annual report 2016, Danish Business Authority

01/01/2016 – 31/12/2016

Serenova A/S (CVR 30532228) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -9,201,359 and a net result of DKK -104,050,880 compared with DKK -33,853,000 the year before. Equity in the 2016 report amounted to DKK 49,652. The solvency ratio was 0.2%. The company had 7 employees in the financial year.

Gross Profit
DKK -9,201,359
Profit/Loss
DKK -104,050,880
Equity
DKK 49,652
Total Assets
DKK 24,640,312
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016--9.2 mio.-104.1 mio.50 t.7
2015153 t.--33.9 mio.61.2 mio.-
2014786 t.--22.2 mio.33.7 mio.-
2012--77 t.-333 t.10.3 mio.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Serenova A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2016

Serenova A/S appoints new auditorDec 20, 2016

As of December 20, 2016, RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Serenova A/S.

Auditor steps down at Serenova A/SDec 20, 2016

As of December 20, 2016, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of Serenova A/S.

Anders Fredslund Pedersen joins the board of Serenova A/SAug 26, 2016

As of August 26, 2016, Anders Fredslund Pedersen has joined the board of directors of Serenova A/S.

Karin Verland leaves the board of Serenova A/SAug 26, 2016

As of August 26, 2016, Karin Verland has left the board of directors of Serenova A/S.

SERENDEX PHARMACEUTICALS A/S changes name to Serenova A/SAug 26, 2016

On August 26, 2016, the company changed its name from SERENDEX PHARMACEUTICALS A/S to Serenova A/S.

Michael Aslo-Petersen joins Serenova A/S as adm. dir.Aug 8, 2016

As of August 8, 2016, Michael Aslo-Petersen is registered as adm. dir. of Serenova A/S.

Kim Arvid Nielsen steps down as adm. dir. of Serenova A/SAug 8, 2016

As of August 8, 2016, Kim Arvid Nielsen has stepped down as adm. dir. of Serenova A/S.

Serenova A/S: The 2015 annual report is outApr 28, 2016

Serenova A/S has published its annual report for 2015. Revenue came to DKK 153,000, and the net result was DKK -33,853,000.

Søren Bech Justesen joins the board of Serenova A/SFeb 9, 2016

As of February 9, 2016, Søren Bech Justesen has joined the board of directors of Serenova A/S.

Joseph Donald deBethizy leaves the board of Serenova A/SFeb 9, 2016

As of February 9, 2016, Joseph Donald deBethizy has left the board of directors of Serenova A/S.

About Serenova A/S

Serenova A/S is a Danish company of the type Aktieselskab based in Solrød Strand, founded in 2008. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named SERENDEX PHARMACEUTICALS A/S and SERENDEX A/S. The management consists of Michael Aslo-Petersen. The company is owned by Sorana Holding A/S. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -167,993 and a net result of DKK 38,663,045 compared with DKK -24,273,688 the year before. Equity in the 2025 report amounted to DKK 105,405,408.

Source: annual report 2025, Danish Business Authority